Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis

BACKGROUND: While immune-based therapies have been approved for extensive-stage small cell lung cancer, there is limited data on the efficacy of immunotherapy in patients with limited-stage disease. METHODS: We used the National Cancer Database to first evaluate factors associated with the inclusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilani, Nadeem, Alley, Evan, Elson, Leah, Nahleh, Zeina, Arteta-Bulos, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Immunotherapy for Lung Cancer: Progress, Opportunities and Challenges
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905481/
https://www.ncbi.nlm.nih.gov/pubmed/33747146
http://dx.doi.org/10.1177/1758835920982806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905481/
https://www.ncbi.nlm.nih.gov/pubmed/33747146
http://dx.doi.org/10.1177/1758835920982806

Ejemplares similares